CIK 0001469443 · Non-accelerated filer<br>Smaller reporting company
Arcadia Biosciences, Inc.
Sign in to watch- Ticker
- RKDA
- Exchange
- Nasdaq
- Industry
- Beverages
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810571538
- Phone
- 214-974-8921
- Business address
- 5956 SHERRY LANE, SUITE 2000, DALLAS, TX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-01 | Carosella Deborah D Director | Grant or award · Stock Option (right to buy) | +23,620 | 56,408 | ||
| 2022-04-11 | PITLIK LAURA Chief Marketing Officer | Grant or award · Stock Option (right to buy) | +31,000 | 129,000 | ||
| 2022-04-11 | PITLIK LAURA Chief Marketing Officer | Grant or award · Stock Option (right to buy) | +23,000 | 129,000 | ||
| 2022-04-11 | Haley Pamela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 232,313 | ||
| 2022-04-11 | Haley Pamela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +38,000 | 232,313 | ||
| 2022-02-02 | Jacot Stanley Jr Chief Executive Officer | Grant or award · Stock Option (right to buy) | +316,108 | 316,108 | ||
| 2021-07-12 | PITLIK LAURA Chief Marketing Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2021-06-02 | Yoder Amy Director | Grant or award · Stock Option (right to buy) | +10,935 | 40,311 | ||
| 2021-06-02 | Murray Lilian Shackelford Director | Grant or award · Stock Option (right to buy) | +10,935 | 34,145 | ||
| 2021-06-02 | Carosella Deborah D Director | Grant or award · Stock Option (right to buy) | +10,935 | 32,788 | ||
| 2021-06-02 | Comcowich Kevin Director | Grant or award · Stock Option (right to buy) | +25,514 | 81,124 | ||
| 2021-06-02 | WALLER GREGORY D Director | Grant or award · Stock Option (right to buy) | +10,935 | 36,157 | ||
| 2021-06-02 | Bolles Albert D. Director | Grant or award · Stock Option (right to buy) | +10,935 | 38,398 | ||
| 2021-05-17 | Cuvelier Chris Chief Growth Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-02-22 | Carosella Deborah D Director | Grant or award · Stock Option (right to buy) | +21,853 | 21,853 | ||
| 2021-01-21 | Plavan Matthew T Chief Executive Officer | Grant or award · Stock Option (right to buy) | +250,000 | 435,450 | ||
| 2021-01-21 | Shultz Randall Chief Technology Officer | Grant or award · Stock Option (right to buy) | +55,000 | 115,000 | ||
| 2021-01-21 | Haley Pamela Chief Financial Officer | Grant or award · Stock Option (right to buy) | +85,000 | 144,313 | ||
| 2020-08-03 | Plavan Matthew T Chief Executive Officer | Purchase | +585 | $3.16 | $2K | 14,285 |
| 2020-08-03 | Shultz Randall Chief Technology Officer | Purchase | +700 | $3.16 | $2K | 13,000 |
Page 3 of 7 · 126 trades